James Larkin, Britta Matthes, Mohamed Azribi, Conor Kearns, Shai Mulinari, Emily Rickard, Frank Moriarty, Tom Fahey, Piotr Ozieranski
{"title":"2015-2019 年间英国制药业支付透明度数据库中用于报告的制药公司方法：内容分析","authors":"James Larkin, Britta Matthes, Mohamed Azribi, Conor Kearns, Shai Mulinari, Emily Rickard, Frank Moriarty, Tom Fahey, Piotr Ozieranski","doi":"10.1101/2024.04.12.24305382","DOIUrl":null,"url":null,"abstract":"<strong>Background</strong> Pharmaceutical companies make hundreds of millions of pounds in marketing/R&D-related payments annually to healthcare organisations and healthcare professionals. UK pharmaceutical industry self-regulatory bodies require member companies who sign up to their code of conduct to publish details of their payments. They are also required to publish the methodologies underlying these payments - methodological notes. This study aimed to analyse UK pharmaceutical companies’ methodological notes and their adherence to the relevant codes of conduct and guidance.","PeriodicalId":501386,"journal":{"name":"medRxiv - Health Policy","volume":"13 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Drug company methodologies used for reporting in the UK pharmaceutical industry payment transparency database between 2015-2019: A content analysis\",\"authors\":\"James Larkin, Britta Matthes, Mohamed Azribi, Conor Kearns, Shai Mulinari, Emily Rickard, Frank Moriarty, Tom Fahey, Piotr Ozieranski\",\"doi\":\"10.1101/2024.04.12.24305382\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<strong>Background</strong> Pharmaceutical companies make hundreds of millions of pounds in marketing/R&D-related payments annually to healthcare organisations and healthcare professionals. UK pharmaceutical industry self-regulatory bodies require member companies who sign up to their code of conduct to publish details of their payments. They are also required to publish the methodologies underlying these payments - methodological notes. This study aimed to analyse UK pharmaceutical companies’ methodological notes and their adherence to the relevant codes of conduct and guidance.\",\"PeriodicalId\":501386,\"journal\":{\"name\":\"medRxiv - Health Policy\",\"volume\":\"13 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"medRxiv - Health Policy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2024.04.12.24305382\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Health Policy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.04.12.24305382","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Drug company methodologies used for reporting in the UK pharmaceutical industry payment transparency database between 2015-2019: A content analysis
Background Pharmaceutical companies make hundreds of millions of pounds in marketing/R&D-related payments annually to healthcare organisations and healthcare professionals. UK pharmaceutical industry self-regulatory bodies require member companies who sign up to their code of conduct to publish details of their payments. They are also required to publish the methodologies underlying these payments - methodological notes. This study aimed to analyse UK pharmaceutical companies’ methodological notes and their adherence to the relevant codes of conduct and guidance.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
